메뉴 건너뛰기




Volumn 76, Issue 8, 2015, Pages 1085-1090

A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE LAUROXIL; CREATINE KINASE; PLACEBO; ARIPIPRAZOLE; DELAYED RELEASE FORMULATION; NEUROLEPTIC AGENT;

EID: 84940404074     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.14m09741     Document Type: Article
Times cited : (107)

References (17)
  • 1
    • 33645793568 scopus 로고    scopus 로고
    • Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care
    • PubMed
    • Ascher-Svanum H, Faries DE, Zhu B, et al. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry. 2006;67(3):453-460. doi:10.408/JCP.v67n0317 PubMed
    • (2006) J Clin Psychiatry. , vol.67 , Issue.3 , pp. 453-460
    • Ascher-Svanum, H.1    Faries, D.E.2    Zhu, B.3
  • 2
    • 84861585734 scopus 로고    scopus 로고
    • Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis
    • PubMed
    • Leucht S, Tardy M, Komossa K, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet. 2012;379(9831):2063-2071. doi:10.1016/S0140-6736(12)60239-6 PubMed
    • (2012) Lancet. , vol.379 , Issue.9831 , pp. 2063-2071
    • Leucht, S.1    Tardy, M.2    Komossa, K.3
  • 3
    • 68049135880 scopus 로고    scopus 로고
    • Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response
    • PubMed
    • Lindenmayer JP, Liu-Seifert H, Kulkarni PM, et al. Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. J Clin Psychiatry. 2009;70(7):990-996. doi:10.408/JCP.08m0421 PubMed
    • (2009) J Clin Psychiatry. , vol.70 , Issue.7 , pp. 990-996
    • Lindenmayer, J.P.1    Liu-Seifert, H.2    Kulkarni, P.M.3
  • 4
    • 71249142333 scopus 로고    scopus 로고
    • Antipsychotic long-acting injections: Mind the gap
    • PubMed
    • Patel MX, Taylor M, David AS. Antipsychotic long-acting injections: mind the gap. Br J Psychiatry suppl. 2009;52(52):S1-S4. doi:10.192/bjp.195.52.s1 PubMed
    • (2009) Br J Psychiatry Suppl. , vol.52 , Issue.52 , pp. S1-S4
    • Patel, M.X.1    Taylor, M.2    David, A.S.3
  • 5
    • 79958233416 scopus 로고    scopus 로고
    • A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia
    • PubMed
    • Tiihonen J, Haukka J, Taylor M, et al. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry. 2011;168(6):603-609. doi:10.176/api.ajp.201.108124 PubMed
    • (2011) Am J Psychiatry. , vol.168 , Issue.6 , pp. 603-609
    • Tiihonen, J.1    Haukka, J.2    Taylor, M.3
  • 6
    • 38349099605 scopus 로고    scopus 로고
    • Treatment strategies to prevent relapse and encourage remission
    • PubMed
    • Kane JM. Treatment strategies to prevent relapse and encourage remission. J Clin Psychiatry. 2007;68(suppl 14):27-30. PubMed
    • (2007) J Clin Psychiatry. , vol.68 , pp. 27-30
    • Kane, J.M.1
  • 7
    • 84887080795 scopus 로고    scopus 로고
    • Longacting injectable versus oral antipsychotics in schizophrenia: A systematic review and metaanalysis of mirror-image studies
    • PubMed
    • Kishimoto T, Nitta M, Borenstein M, et al. Longacting injectable versus oral antipsychotics in schizophrenia: a systematic review and metaanalysis of mirror-image studies. J Clin Psychiatry. 2013;74(10):957-965. doi:10.408/JCP.13r0840 PubMed
    • (2013) J Clin Psychiatry. , vol.74 , Issue.10 , pp. 957-965
    • Kishimoto, T.1    Nitta, M.2    Borenstein, M.3
  • 8
    • 84879947404 scopus 로고    scopus 로고
    • Oral versus long-acting injectable antipsychotics in the treatment of schizophrenia and special populations at risk for treatment nonadherence: A systematic review
    • PubMed
    • Zhornitsky S, Stip E. Oral versus long-acting injectable antipsychotics in the treatment of schizophrenia and special populations at risk for treatment nonadherence: a systematic review. Schizophr Res Treatment. 2012;2012:407171. doi:10.15/2012/407171 PubMed
    • (2012) Schizophr Res Treatment. , vol.2012 , pp. 407171
    • Zhornitsky, S.1    Stip, E.2
  • 9
    • 84901754690 scopus 로고    scopus 로고
    • Making the leap from daily oral dosing to long-acting injectables: Lessons from the antipsychotics
    • PubMed
    • Remenar JF. Making the leap from daily oral dosing to long-acting injectables: lessons from the antipsychotics. Mol Pharm. 2014;11(6):1739-1749. doi:10.1021/mp5070m PubMed
    • (2014) Mol Pharm. , vol.11 , Issue.6 , pp. 1739-1749
    • Remenar, J.F.1
  • 10
    • 84922554449 scopus 로고    scopus 로고
    • Relative bioavailability and safety of aripiprazole lauroxil, a novel once-monthly, long-acting injectable atypical antipsychotic, following deltoid and gluteal administration in adult subjects with schizophrenia
    • PubMed
    • Turncliff R, Hard M, Du Y, et al. Relative bioavailability and safety of aripiprazole lauroxil, a novel once-monthly, long-acting injectable atypical antipsychotic, following deltoid and gluteal administration in adult subjects with schizophrenia. Schizophr Res. 2014;159(2-3):404-410. doi:10.1016/j.schres.2014.09.021 PubMed
    • (2014) Schizophr Res. , vol.159 , Issue.2-3 , pp. 404-410
    • Turncliff, R.1    Hard, M.2    Du, Y.3
  • 12
    • 0023606101 scopus 로고
    • The positive and negative syndrome scale (PANSS) for schizophrenia
    • PubMed
    • Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276. doi:10.1093/schbul/13.2.261 PubMed
    • (1987) Schizophr Bull. , vol.13 , Issue.2 , pp. 261-276
    • Kay, S.R.1    Fiszbein, A.2    Opler, L.A.3
  • 13
    • 0000238671 scopus 로고
    • The clinician global severity and impression scales
    • Superintendent of Documents, US Government Printing Office, Publication No. 76-338. Washington, DC: US Department of Health, Education, and Welfare
    • Guy W. The clinician global severity and impression scales. ECDEU Assessment Manual for Psychopharmacology. Superintendent of Documents, US Government Printing Office, Publication No. 76-338. Washington, DC: US Department of Health, Education, and Welfare. 1976:218-222.
    • (1976) ECDEU Assessment Manual for Psychopharmacology , pp. 218-222
    • Guy, W.1
  • 14
    • 0001669952 scopus 로고
    • A stage wise rejective multiple test procedure based on a modified Bonferroni test
    • Hommel G. A stage wise rejective multiple test procedure based on a modified Bonferroni test. Biometrika. 1988;75(2):383-386. doi:10.1093/biomet/75.2.383
    • (1988) Biometrika. , vol.75 , Issue.2 , pp. 383-386
    • Hommel, G.1
  • 15
    • 84903896379 scopus 로고    scopus 로고
    • Aripiprazole once-monthly for treatment of schizophrenia: Double-blind, randomised, non-inferiority study
    • PubMed
    • Fleischhacker WW, Sanchez R, Perry PP, et al. Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study. Br J Psychiatry. 2014;205(2):135-144. doi:10.192/bjp.bp.13.134213 PubMed
    • (2014) Br J Psychiatry. , vol.205 , Issue.2 , pp. 135-144
    • Fleischhacker, W.W.1    Sanchez, R.2    Perry, P.P.3
  • 16
    • 84861837563 scopus 로고    scopus 로고
    • Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: A 52-week, multicenter, randomized, double-blind, placebo-controlled study
    • PubMed
    • Kane JM, Sanchez R, Perry PP, et al. Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2012;73(5):617-624. doi:10.408/JCP.1m07530 PubMed
    • (2012) J Clin Psychiatry. , vol.73 , Issue.5 , pp. 617-624
    • Kane, J.M.1    Sanchez, R.2    Perry, P.P.3
  • 17
    • 84922474822 scopus 로고    scopus 로고
    • Aripiprazole once-monthly in the acute treatment of schizophrenia: Findings from a 12-week, randomized, double-blind, placebocontrolled study
    • PubMed
    • Kane JM, Peters-Strickland T, Baker RA, et al. Aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebocontrolled study. J Clin Psychiatry. 2014;75(11):1254-1260. doi:10.408/JCP.14m09168 PubMed
    • (2014) J Clin Psychiatry. , vol.75 , Issue.11 , pp. 1254-1260
    • Kane, J.M.1    Peters-Strickland, T.2    Baker, R.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.